Tribbles homolog 3 (TRB3, also known as TRIB3, NIPK and SKIP3), a human homolog of Drosophila Tribbles, has been found to interact with a variety of signaling molecules to regulate diverse cellular functions. Here, we report that TRB3 is a novel SMAD3-interacting protein. Expression of exogenous TRB3 enhanced the transcriptional activity of SMAD3, whereas knocking down endogenous TRB3 reduced the transcriptional activity of SMAD3. The kinase-like domain (KD) of TRB3 was responsible for the interaction with SMAD3 and the regulation of SMAD3-mediated transcriptional activity. In addition, TGF-b1 stimulation or overexpression of SMAD3 enhanced the TRB3 promoter activity and expression, suggesting that there is a positive feedback loop between TRB3 and TGF-b-SMAD3 signaling. Mechanistically, TRB3 was found to trigger the degradation of SMAD ubiquitin regulatory factor 2 (Smurf2), which resulted in a decrease in the degradation of SMAD2 and phosphorylated SMAD3. Moreover, TRB3-SMAD3 interaction promoted the nuclear localization of SMAD3 because of the interaction of TRB3 with the MH2 domain of SMAD3. These effects of TRB3 were responsible for potentiating the SMAD3-mediated activity. Furthermore, knockdown of endogenous TRB3 expression inhibited the migration and invasion of tumor cells in vitro, which were associated with an increase in the expression of Ecadherin and a decrease in the expression of Twist-1 and Snail, two master regulators of epithelial-to-mesenchymal transition, suggesting a crucial role for TRB3 in maintaining the mesenchymal status of tumor cells. These results demonstrate that TRB3 acts as a novel SMAD3-interacting protein to participate in the positive regulation of TGF-b-SMAD-mediated cellular biological functions.
Introduction
The transcription factor SMAD3 is a downstream modulator of TGFb signaling, and is involved in regulating a variety of physiological and pathological processes, such as development, differentiation, apoptosis, immunomodulation, fibrogenesis and carcinogenesis (Kim et al., 2005) . Following the activation and phosphorylation by TGF-b type I receptor, SMAD3 forms a heterodimer with SMAD4. The activated heteromeric SMAD complex is translocated into the nucleus and regulates the transcription of target genes. The specificity for target genes and biological effects of SMAD3-mediated signaling is under the control of many SMAD-interacting proteins including cytoplasmic partners (Conery et al., 2004; Xue et al., 2010; Seong et al., 2007) and transcriptional cofactors (Ding et al., 2009; Feng et al., 2000) . The epithelial-to-mesenchymal transition (EMT) is important in development, as well as in fibrogenesis and tumor metastasis. SMAD3 is a key signaling molecule for the induction of EMT by TGF-b and overexpression of SMAD3 enhanced metastases of mice injected with MCF10CA1a tumor cells but SMAD3DC, the dominant-negative mutant, suppressed the metastases (Tian et al., 2003) .
Tribbles was first identified in Drosophila as an inhibitor of mitosis that regulates cell proliferation, migration and morphogenesis during development (Grosshans and Wieschaus, 2000; Mata et al., 2000; Seher and Leptin, 2000) . In mammals, there are three Tribbles homologs -TRB1, TRB2 and TRB3. They are considered to be members of the pseudokinase family, which contain a Ser/Thr protein kinase-like domain but lack the ATP binding pocket and catalytic residues. Despite lacking kinase activity, tribbles has a scaffold-like function and participates in protein complex assembly. TRB3 is the best-studied member of the mammalian tribbles family. The interacting partners of TRB3 range from transcription factors, ubiquitin ligase, BMP type II receptor to members of the MAPK and PI3K signaling pathways. Through interacting with these proteins, it coordinates crucial cellular processes, including glucose and lipid metabolism, apoptosis, adipocyte differentiation, cell stress and regulation of collagen expression (Bezy et al., 2007; Chan et al., 2007; Du et al., 2003; Ohoka et al., 2005; Qi et al., 2006; Tang et al., 2008) . Recently, emerging evidence suggests that the three mammalian tribbles homologs are crucial modulators of tumorogenesis. TRB1 and TRB2 are both involved in myeloid leukemogenesis (Jin et al., 2007; Keeshan et al., 2006) , whereas, TRB3 is highly expressed in many human tumor cell lines and in several human tumor tissues (Bowers et al., 2003; Xu et al., 2007) . However, the function and mechanism of interaction of TRB3 in cancer remains unknown.
In an effort to discover SMAD3-interacting proteins using a yeast two-hybrid screening system, we identified a number of molecules, including TRB3, that physically interact with SMAD3 After 24 hours of transfection, cells were incubated in the presence (gray bars) or absence (black bars) of TGF-b1 for another 24 hours and then the luciferase activity was measured. (B) HepG2 cells were transfected with 500 ng of 3TP-lux, 10 ng of TK-Renilla, and with (+) or without (-) 1.0 mg of SMAD3-Myc and 1.0 mg of TRB3 for 24 hours. The cells were incubated with or without TGF-b1 (10 ng/ml) for another 24 hours and luciferase activity was measured. (C) The effect of TRB3 on TGF-b signaling is SMAD3 dependent. HEK293T cells were transiently transfected in 12-well plates with 500 ng of SBE4-luc, 10 ng of TKRenilla and with (+) or without (-) 2.0 mg of HA-tagged TRB3, and 50 nM of universal scrambled negative control siRNA duplexes or siRNA duplexes targeting SMAD3. After 24 hours of transfection, cells were incubated in the presence (gray bars) or absence (black bars) of TGF-b1 for another 24 hours and then the luciferase activity was measured. (D) HepG2 cells were transiently transfected with TRB3-HA plasmid. After 24 hours of transfection, cells were incubated in the presence (+) or absence (-) of TGF-b1 for another 24 hours. Whole cell extracts were prepared and the expression of p21, PAI-1, SMAD2/3, and the phosphorylation of Ser465 and Ser467 of SMAD2, and Ser423 and Ser425 of SMAD3 (pSmad2 and 3, respectively) were analyzed by western blotting. Values are means ¡ s.e.m. of three independent assays. *P,0.05, **P,0.01, ***P,0.001. (Xue et al., 2010) . In this study, the functional significance and regulatory mechanism of the TRB3-SMAD3 interaction was further explored. We found that the TRB3-SMAD3 interaction plays an important role in the regulation of SMAD3-mediated transcriptional activity and in the reciprocally positive regulation of TRB3 expression. Knockdown of endogenous TRB3 expression inhibited the migration and invasion of HepG2 cells in vitro, through inhibition of EMT. Our studies suggest a pivotal role of TRB3 in tumor progression and metastasis.
Results

Identification of TRB3 as an interacting protein of SMAD3
In a previous study, we identified a number of proteins, including TRB3, as partners of SMAD3 in a yeast two-hybrid screening system (Xue et al., 2010) . To confirm the TRB3-SMAD3 interaction in mammalian cells, co-immunoprecipitation assay was carried out using HEK293T cells co-transfected with Myc-SMAD3 and HA-TRB3. TRB3 could be precipitated with SMAD3 ( Fig. 1A) and the kinase-like domain (KD) of TRB3 mediated the interaction (Fig. 1B) . To determine whether TRB3 specifically interacted with SMAD3 or generally interacted with other members of the SMAD family, we also examined the possible interaction of HA-TRB3 with Myc-SMAD2 and Myc-SMAD4. We found that SMAD2 and SMAD4 could also be coimmunoprecipitated with HA-tagged TRB3, similar to SMAD3 (supplementary material Fig. S1A ). SMAD3 is a downstream molecule of TGF-b1 signaling, so we therefore examined whether TGF-b1 regulated the endogenous TRB3-SMAD3 interaction. In the absence of TGF-b1, endogenous TRB3 was weakly associated with SMAD3. However, TGF-b1 stimulation enhanced this interaction (Fig. 1C) . Because phosphorylation of the C-terminal serine residues in SMAD3 is a crucial step in TGF-b1 signaling (Massagué et al., 2005) , we tested whether the phosphorylation status of SMAD3 might regulate the SMAD3-TRB3 interaction. Fig. 3 . Silencing endogenous TRB3 inhibits SMAD3-mediated transcription and the expression of TGF-b1 target genes. (A) Silencing TRB3 inhibits SBE4-luc reporter activity. HepG2 cells stably expressing control shRNA or TRB3 shRNA were transfected with the SBE4-luc reporter construct for 24 hours. The cells were incubated with (gray bars) or without (black bars) TGF-b1 (10 ng/ml) for another 24 hours. The cells were harvested and luciferase activity was measured. (B) Silencing of TRB3 inhibits 3TP-lux reporter activity. The assay was conducted as described in A, except for transfecting with the 3TP-lux reporter construct instead of SBE4-luc reporter construct. (C) Silencing TRB3 inhibits the expression of TGF-b signaling target genes. HepG2 cells stably expressing control shRNA or TRB3 shRNA were incubated with (+) or without (-) TGF-b1 (10 ng/ml) for 24 hours. Whole cell extracts were prepared and the expression of p21, PAI-1, SMAD2/3, and the phosphorylation of Ser465 and Ser467 of SMAD2 and Ser423 and Ser425 of SMAD3 (p-Smad2 and 3, respectively) were analyzed by western blotting. Values are means ¡ s.e.m. of three independent assays. **P,0.01. (C) Overexpression of SMAD3 causes TRB3 induction. HEK293T cells were transiently transfected with the indicated amounts of SMAD3-expressing plasmid plus the TRB3 promoter luciferase (pTRB3-luc) plasmid. After 24 hours of transfection, the cells were incubated with (grey bars) or without (black bars) TGF-b1 (10 ng/ml) for another 24 hours and luciferase activity was measured. Values are means ¡ s.e.m. of three independent assays. ***P,0.001.
We found that the SMAD3D mutant, which has three serine residues replaced by aspartate to mimic phosphorylation, bound to TRB3 as well as the wild-type SMAD3 did. By contrast, the 3A mutant, lacking the phosphorylation sites, showed no interaction (Fig. 1D) . Using a GST pull-down assay, TRB3 was found to bind to a GST-SMAD3 fusion protein in vitro but not GST protein alone (Fig. 1E) . These results not only provide evidence demonstrating an interaction between SMAD3 and TRB3 but also show that the KD of TRB3 is crucial for the interaction. However, the phosphorylation status of SMAD3 is important, but not absolutely required, for this interaction because the nonphosphorylated GST-SMAD3 fusion protein expressed in Escherichia coli can also interact with TRB3 (Fig. 1E ).
TRB3 regulates SMAD3-mediated transcription and target gene expression
To determine the effect of the TRB3-SMAD3 interaction on SMAD3-mediated transcription, HEK293T cells were cotransfected with Myc-SMAD3, HA-tagged TRB3 or its truncated mutants, and the SBE4-luciferase (luc) reporter, which contains four copies of a SMAD consensus-binding element. Together with SMAD3, TRB3 overexpression induced an increase in SBE4-luc reporter activity and the KD fragment but not the N-or C-terminus of TRB3 that induced the SBE4-luc activity. Stimulation with TGFb1 further strengthened the TRB3-induced activity ( Fig. 2A) . Additionally, we found that TRB3 induced SMAD2-mediated transcriptional activity (supplementary material Fig. S1B ).
Next, we assessed the effect of TRB3 on TGF-b1-responsive gene transcription. Overexpression of TRB3 promoted an increase in 3TP-lux reporter activity in the presence or absence of TGF-b1 (Fig. 2B ). This effect of TRB3 is SMAD3 dependent because SMAD3 knockdown led to a significant reduction in the SBE4-luc activity induced by TRB3 expression and TGF-b1 stimulation (Fig. 2C) .
We then examined the regulatory effect of TRB3 on TGF-b1-SMAD3 signaling and target gene expression. We found that overexpression of TRB3 enhanced the expression of PAI-1 and p21 even in the absence of TGF-b1. Interestingly, TRB3 overexpression promoted the phosphorylation of SMAD3 and upregulated the expression of SMAD2 but had little effect on the phosphorylation of SMAD2 (Fig. 2D ), whereas knock down of TRB3 with sequence specific shRNA (Du et al., 2003) reduced the SBE4-luc and 3TP-lux reporter activity to 50% of the control level even in the presence of TGF-b1 (Fig. 3A,B ). In addition, knock down of TRB3 reduced (A) Cell migration was measured using transwell assays for parental, control-shRNA and TRB3-shRNA HepG2 cells. The cells were plated in the upper chamber of the filters that had been coated with fibronectin on the underside, and stimulated with TGF-b1 (10 ng/ml) for 24 hours or left unstimulated. Cells migrating to the underside of the transwell insert were measured. (B) A transwell invasion assay was performed as described in A, except that the chambers were coated with basement membrane Matrigel (30 mg/well) and cells migrating to the underside of the insert were measured 48 hours after the start of the experiment. (C) Cell invasion was measured using transwell assays for parental, control-shRNA and TRB3-shRNA HCT-8 cells. 24 hours after plating, the cells migrating to the underside of the transwell insert were measured. The expression levels of TRB3 in these cells were detected by western blotting. (D) Transwell migration assays were performed using NIH3T3 cells transfected with or without TRB3-HA for 24 hours. The cells migrating to the underside of the transwell insert were measured. The expression levels of TRB3 in these cells were detected by western blot. The value from parental cells was arbitrarily set at 100%. Values are means ¡ s.e.m. of three independent assays. **P,0.01. The original magnification of all images was 2006. Parental HepG2 cells and cells expressing either control shRNA or TRB3 shRNA were treated as described in A; whole cell extracts were prepared and the expression of E-cadherin and a-SMA was examined by immunoblotting. (C) NIH3T3 cells were transiently transfected with TRB3-HA for 24 hours. Whole cell extracts were prepared, and the expression of E-cadherin, a-SMA, TRB3 (anti-HA antibody) and actin were analyzed by western blotting. (D) Semi-quantitative RT-PCR analysis of the E-cadherin repressors. Cells were grown to confluence in six-well plates. Total RNA was extracted from parental, control-shRNA and TRB3-shRNA HepG2 cells. The expression of mRNA encoding for Twist-1, Twist-2, Zeb-2, Snail, Slug, TRB3 and b-actin was determined by RT-PCR using specific primer sets. The value from parental cells was arbitrarily set at 1.0. (E) Protein expression level of the E-cadherin repressors. Cells were grown to confluency in six-well plates. Whole cell extracts were prepared from control-shRNA and TRB3-shRNA HepG2 cells. The expression of Twist-1, Snail, Slug, TRB3 and actin were analyzed by western blotting. The value from control-shRNA cells was arbitrarily set at 1.0. Values are means ¡ s.e.m. of three independent assays. **P,0.01. the expression of PAI-1, p21, SMAD2 and phosphorylated SMAD3 (Fig. 3C) , which was consistent with the result of Fig. 2D . Taken together, these results indicated that TRB3 is a positive modulator of TGF-b-SMAD3 signaling.
TGF-b1-SMAD3 stimulates TRB3 expression and activates TRB3 promoter activity Because TRB3 promoted SMAD3-mediated transcriptional activity, we wondered if the expression of TRB3 could be regulated by TGF-b1-SMAD3 signaling. We found that TGF-b1 induced a time-dependent expression of TRB3 as well as the SMAD3-targeted proteins, such as p21 and PAI-1 in HepG2 cells (Fig. 4A) . The SMAD3-targeted proteins were induced much more quickly than TRB3. The expression of p21 and PAI-1 was induced 12 hours after TGF-b1 stimulation, whereas the phosphorylation of SMAD3 was observed 1 hour after stimulation and a high level of phosphorylation occurred at 6 hours after stimulation. TGF-b1 stimulation also induced a time- Fig. 7 . See next page for legend. dependent expression of these proteins in HCT-8 cells, a human colorectal carcinoma cell line (supplementary material Fig. S2 ). Using the promoter region of human TRB3 (-1038 , +847) as a luciferase reporter system (TRB3-luc; Fig. 4B ), we found that overexpression of SMAD3 induced a concentration-dependent transactivation of TRB3 and that stimulation with TGF-b1 further induced its activation (Fig. 4C) . Taken together with the data in Figs 2 and 3, our study suggests that TRB3 can be regulated by TGF-b1-SMAD3 signaling, and there exists a positive feedback loop between TRB3 and TGF-b1-SMAD3 signaling.
TRB3 is essential for the migration and invasion of tumor cells TRB3 mRNA is highly expressed in several human tumor tissues and multiple human tumor cell lines (Bowers et al., 2003; Xu et al., 2007) , indicating a potential role of TRB3 in tumorigenesis and tumor progression. A large number of studies have provided strong evidence for the role of TGF-b1-SMAD3 in tumor invasion and metastasis (Micalizzi et al., 2009; Wesolowska et al., 2007) . Therefore, we examined the regulatory effect of TRB3 on migratory and invasive ability in HepG2 cells using transwell migration and invasion assays. We found that TGF-b1 promoted the migration and invasion of HepG2 cells, whereas knocking down of TRB3 blocked cell migration and invasion in the absence or presence of TGF-b1 (Fig. 5A,B) . HCT-8 is a human colorectal carcinoma cell line, with a high level of expression of TRB3. Knockdown of TRB3 inhibited cell invasion as observed in HepG2 cells (Fig. 5C ). By contrast, overexpression of TRB3 in NIH3T3 cells, which express low levels of endogenous TRB3, promoted migration of the cells (Fig. 5D ). Taken together, these data suggest that TRB3 participates in the regulation of tumor cells migration and invasion.
TRB3 is required for maintaining the mesenchymal status of HepG2 cells Epithelial-mesenchymal transition (EMT) plays an important role in the conversion of early stage tumors into invasive malignancies (Kang and Massagué, 2004) . Epithelial cells undergoing EMT typically lose the expression of epithelial markers such as Ecadherin and acquire the expression of mesenchymal markers including a-SMA and vimentin. Because we found that silencing endogenous TRB3 blocked the migration and invasion of HepG2 cells, we reasoned that TRB3 might have a role in the regulation of EMT. We examined EMT markers in HepG2 cells. As a hepatoma cell line, parental and control short hairpin (shRNA)-expressing HepG2 cells showed modest a-SMA staining and lost the staining of E-cadherin (Fig. 6A) . It is generally accepted that TGF-b can promote an invasive phenotype of tumor cells in later stages of carcinoma by inducing EMT. We found that TGF-b1 stimulation enhanced the expression of a-SMA but reduced the expression of E-cadherin in HepG2 cells. Silencing TRB3 significantly reduced the expression of a-SMA but markedly enhanced the expression of epithelial marker E-cadherin, even in the presence of TGF-b1 (Fig. 6A) . Western blot analysis of cellular extracts from TRB3-silenced or TRB3-overexpressing cells confirmed the expression changes of a-SMA and E-cadherin (Fig. 6B,C) .
We next examined the effect of TRB3 on the expression of the Ecadherin repressors known to regulate EMT. RT-PCR analysis showed that Zeb-2 and slug (snail2) were constitutively expressed in parental HepG2 cells and in the control-shRNA and TRB3-shRNA transfectants. However, expression of Twist-2 mRNA was undetectable in all the three cell types. The expression of Twist-1 and Snail, two transcription factors contributing to EMT and metastasis, was detectable in parental HepG2 cells and the controlshRNA transfectants but was significantly decreased in TRB3-shRNA transfectants (Fig. 6D) . Western blotting confirmed the expression change of Twist-1 and Snail (Fig. 6E) . These data indicate that TRB3 is crucial in maintaining the mesenchymal status of HepG2 cells and in the regulation of TGF-b1-induced EMT.
TRB3-SMAD3 interaction maintains the nuclear localization of SMAD3
Previous work indicated that SMAD3 is distributed predominantly in the cytoplasm (Xu et al., 2002) but TRB3 localizes in the nucleus (Xu et al., 2007) in quiescent cells. When SMAD3 and TRB3 were coexpressed, SMAD3 was concentrated and colocalized with TRB3 in the nucleus (Fig. 7A) . To confirm those observations in intact cells, nuclear and cytosolic fractions were extracted from HepG2 cells transfected with TRB3-HA-expressing plasmid and the level of SMAD3 in each fraction was determined. The cytosolic and nuclear fractions were immunoblotted for histone H3 as a nuclear marker and GAPDH as a cytosolic marker. We found that no histone H3 was detected in the cytosolic fractions and no GAPDH was detected in the nuclear fractions, verifying an efficient isolation of these fractions (Fig. 7B) . Consistent with immunofluorescence results, SMAD3 localized predominantly in After 24 hours of transfection, the nuclear and cytosolic fractions were extracted and assessed by western blot analysis. To verify separation of nuclear and cytosolic fractions, histone H3 (nuclear marker) and GAPDH (cytosolic marker) were immunoblotted. C.E. and N.E., cytosolic extract and nuclear extract, respectively. Values are means ¡ s.e.m. of three independent assays. The value from untransfected HepG2 cells was arbitrarily set at 1.0. (C) HepG2 cells expressing either control shRNA or TRB3 shRNA were stimulated with TGF-b1 (10 ng/ml) for 2 hours or left untransfected. The cells were immunostained with an anti-SMAD3 antibody, followed by FITC-conjugated anti-rabbit secondary antibody. DAPI was used to stain the nuclei. Scale bars: 30 mm. The number of cells showing a predominant nuclear distribution of SMAD3 was divided by the total number of cells to obtain the percentage of cells with nuclear localization. Values are means ¡ s.e.m. of three independent experiments. (D) HepG2 cells expressing either control shRNA or TRB3 shRNA were stimulated with TGF-b1 (10 ng/ ml) for 2 hours or left untransfected. The nuclear and cytosolic fractions were extracted and assessed as described in B. Values are means ¡ s.e.m. of three independent assays. Cells expressing control shRNA without TGF-b1 stimulation were used as a control and the value from these cells was arbitrarily set at 1.0. (E) Cell lysates from HEK293T overexpressing TRB3-HA were incubated with equal amounts of GST-MH1, GST-MH2 or GST-linker and analyzed by western blotting using the anti-HA antibody. The presence of the GST fusion proteins (arrows) was confirmed by staining gels with Coomassie Blue. Data is representative of two assays with identical results. the cytoplasm under basal condition. Transient transfection of TRB3-HA resulted in accumulation of SMAD3 in the nucleus (Fig. 7B) . The effect of endogenous TRB3 on SMAD3 nuclear localization was also examined. As shown in Fig. 7C ,D, knocking down TRB3 decreased the nuclear accumulation of SMAD3 and inhibited TGF-b1-induced nuclear translocation of SMAD3 to a certain extent. Because SMAD proteins are continuously shuttling between the nucleus and the cytoplasm regardless of the presence of a TGF-b signal (Hill, 2009) , we further examined how TRB3 regulates the localization of SMAD3. SMAD3 consists of two globular domains, namely the N-terminal MH1 domain and the Cterminal MH2 domain, coupled by a linker region (Fig. 7E, upper  panel) . The MH2 domain of SMAD3 is responsible for nuclear export of SMAD3 through interaction with exportin 4 (Kurisaki et al., 2006) . Using a GST pull-down assay we detected which domain of SMAD3 interacted with TRB3. As illustrated in the lower panel of Fig. 7E , there was clear interaction between TRB3 and GST-MH2, but not TRB3 and GST-linker. A weak interaction between GST-MH1 and TRB3 was also observed. These results indicate that TRB3 binds directly to the MH2 domain of SMAD3, which interferes with the nuclear export of SMAD3 (Kurisaki et al., 2006) .
TRB3 interacts with Smurf2 and promotes its degradation
Overexpression of TRB3 increased the phosphorylation of SMAD3, whereas silencing of TRB3 caused the opposite effect. Because TRB3 is a pseudokinase and lacks the kinase activity, it might regulate the phosphorylation of SMAD3 by changing the stability of phosphorylated SMAD3. Wu et al. reported recently that phosphorylated SMAD3 is a target for SMAD ubiquitin regulatory factor 2 (Smurf2) ubiquitylation . TRB3 has been reported to interact with Smurf1, which shows a high homology with Smurf2 , and to promote its degradation through the ubiquitin-proteasome pathway (Chan et al., 2007) . We thus examined the regulatory effect of TRB3 on the expression of Smurf2 in HepG2 cells. We found that silencing TRB3 increased the protein but not mRNA expression of Smurf2 (Fig. 8A,B) , whereas increasing TRB3-HA expression decreased the levels of Smurf2 (Fig. 8C) . Moreover, the immunoprecipitation assay revealed a strong interaction between TRB3 and Smurf2 (Fig. 8D) . We further determined whether the ubiquitylation of Smruf2 was TRB3 dependent. Compared with the control cells, many more ubiquitylated proteins (molecular mass .86 kDa) were immunoprecipitated with anti-Myc (Smurf2-Myc) from TRB3-transfected cells (Fig. 8E) , suggesting that TRB3 is a negative regulator of Smurf2 by promoting Smurf2 ubiquitylation. Indeed, knockdown of SMURF2 using SMURF2-targeting siRNA duplexes caused the accumulation of SMAD2 and phosphorylated SMAD3 in the cells (supplementary material Fig. S3 ). Similar results had been reported previously Zhang et al., 2001; Wu et al., 2008) . Therefore we investigated whether TRB3 regulation of SMAD3-mediated transcriptional activity was Smurf2 dependent. We found that expression of TRB3 enhanced SBE4-luc reporter activity but this effect was significantly attenuated in the cells coexpressing TRB3 and Smurf2 (Fig. 8F ). Taken together, our studies indicate that TRB3 augments TGF-b1-SMAD3 signaling by promoting ubiquitylation and degradation of Smurf2, which attenuates the degradation of SMAD2 and phosphorylated SMAD3 (Fig. 9) .
Discussion
The major finding of this study is that TRB3, an intracellular adaptor molecule, augments TGF-b1-SMAD3-mediated transcriptional activity and cellular functions by physically interacting with SMAD2/3. Knockdown of TRB3 expression in tumor cells significantly inhibits the invasive and metastatic ability of the cells by promoting mesenchymal-epithelial transition. Moreover, TRB3 interacts with SMAD2 and SMAD4, two members of TGF-b-SMAD signaling family. The highly conserved MH2 domain of the SMAD proteins, as indicated previously (Massagué et al., 2005) might mediate their interaction with TRB3. However, the highly conserved tribbles kinase-like domain in TRB3 is also necessary for TRB3-SMAD3 interaction and SMAD3-mediated transcription activity, suggesting an important role for the biological function of this region. Although only receptors and SMAD proteins are essential components of the canonical TGF-b1-SMAD pathway, this pathway can be modulated by, and have a crosstalk with, other signaling molecules through interaction with SMAD2/3 . Thus, our studies indicate that TRB3 is a novel partner and modulator of TGF-b-SMAD3 signaling, which might play an important role in tumor progression and metastasis.
There is evidence that the activation and nuclear translocation of SMAD3 results from TGF-b-induced phosphorylation at the C-terminal serine residues of SMAD3 (Massagué, 1998; Moustakas et al., 2001 ). The observations that the positive regulation of the endogenous TRB3-SMAD3 interaction by TGF-b1 and that the SMAD3D mutant can interact with TRB3 confirm that the phosphorylation of SMAD3 is important for the formation of the TRB3-SMAD3 complex. However, we found that GST-SMAD3 can also interact with TRB3 in pull-down assay while GST-SMAD3 fusion protein cannot be phosphorylated when it is expressed in E. coli. These results suggest that the subcellular localization rather than the phosphorylation status is essential for the interaction between TRB3 and SMAD3. In particular, the enhancement of the TRB3-SMAD3 interaction when SMAD3 is phosphorylated might occur because phosphorylated SMAD3 moves into the nucleus more readily (Massagué, 1998; Moustakas et al., 2001 ) and is therefore more accessible for interaction. Moreover, previous work indicates that SMAD proteins are continuously shuttling between the nucleus and the cytoplasm and the MH2 domain of SMAD3 is responsible for nuclear export of SMAD3 (Kurisaki et al., 2006) . We found in the current study that TRB3 interacts with the MH2 domain of SMAD3, and overexpression of TRB3 increases the nuclear localization of SMAD3. On the basis of these observations, we propose that the interaction between TRB3 and the MH2 domain of SMAD3 might form a steric hindrance to the interaction of SMAD3 with exportin 4, which blocks the nuclear export of SMAD3. Such an effect mimics a continuous activation of TGF-b-SMAD3 to exert its transcriptional activity and other cellular actions (Fig. 9) . Indeed, Chan et al. recently report that TRB3 interacts with BMPRII and positively regulates BMP and TGF-b signaling. Because TRB3 is predominantly localized in the nucleus, these authors surmised that TRB3 might play a direct role in the transcriptional regulation of BMP and TGF-b target genes in concert with SMAD proteins in the nucleus (Chan et al., 2007) .
SMAD proteins are crucial intracellular mediators of TGF-b signaling pathways. An alteration in SMAD protein levels can profoundly affect signaling transduction and cellular functions. Smurf2 is a HECT class ubiquitin E3 ligase, which can interact with SMAD1, SMAD2 and SMAD3 . Several studies have shown that Smurf2 ubiquitylates and degrades SMAD1 and SMAD2, but not SMAD3 at steady state Zhang et al., 2001) . Recently, Wu et al. reported phosphorylated SMAD3 is a target for Smurf2 ubiquitylation . We found that TRB3 interacts with Smurf2 to promote degradation of Smurf2. Overexpression of TRB3 increases, whereas silencing of TRB3 decreases the levels of both SMAD2 and phosphorylated SMAD3. SMAD2 and SMAD3 (1) TRB3 keeps SMAD3 in the nucleus by physically interacting with it; (2) TRB3 forms a complex with Smurf2 that leads to the degradation of Smurf2, which in turn stabilizes the targets of Smurf2, such as SMAD2 and phosphorylated SMAD3 to enhance reciprocally the TGF-b-SMAD3 signaling activity.
are both activated in response to TGF-b1 and act, in cooperation with SMAD4, as effectors of the TGF-b response (Massagué et al., 2005) . Thus, augmentation of TGF-b signaling by TRB3 may not only rely on the decrease in the expression of Smurf1 (Chan et al., 2007) , but also depend on the TRB3 downregulation of Smurf2 (Fig. 8) to maintain the stability of both phosphorylated SMAD3 and SMAD2.
TGF-b1 plays an important role in tumor progression. An increased level of TGF-b1 has been observed in many human tumors and enhanced TGF-b1 can promote tumor invasion or metastasis in the established tumor (Bierie and Moses, 2006) . In the present study, we found that silencing TRB3 inhibits cell migration and invasion, even in the presence of TGF-b1. Overexpression of TRB3 augments SMAD3-mediated transcription activity. TGF-b-SMAD3 signaling in turn upregulates the expression of TRB3, thus establishing a positive feedback loop that amplifies TGF-b-SMAD3 signaling. Given that TRB3 is highly expressed in human tumors (Bowers et al., 2003) and it positively promotes TGF-b-SMAD3 signaling, as demonstrated by this study, the expression level of TRB3 may, at least partly, be responsible for the different roles of TGF-b-SMAD3 signaling in tumor inhibition or tumor progression at the different stages of tumor development (Bierie and Moses, 2006) .
EMT is crucial in the conversion of early stage tumors into invasive ones during tumor progression, because it allows tumor cells to infiltrate the adjacent tissue, gain invasive properties and ultimately form metastases at distal sites (Lee et al., 2006) . TGF-b-SMAD3 signaling regulates EMT through SMAD3-dependent orindependent mechanisms (Xu et al., 2009) . We found that silencing TRB3 increases the expression of E-cadherin and decreases the expression of mesenchymal marker a-SMA, suggesting that TRB3 is involved in maintaining the mesenchymal status of tumor cells. The ability of TRB3 to maintain the mesenchymal status of cancer cells could result from TRB3 enhancing SMAD3-mediated transcription activity. Several developmentally important genes, including those encoding for Twist-1, Twist-2, Snail, Slug and Zeb-2 have been found to induce EMT through repression of the gene encoding E-cadherin, a hallmark of EMT (Peinado et al., 2007) . Indeed, in our study, silencing TRB3 attenuated the expressions of Twist-1 and Snail that have been identified as promoters of invasion and metastasis in various types of human cancer (Batlle et al., 2000; Yang et al., 2004; Yang et al., 2008) . Moreover, Snail can form a Snail-SMAD3 or -SMAD4 transcriptional repressor complex to promote TGF-b-mediated EMT (Vincent et al., 2009 ). Thus, TRB3 induces EMT, cell migration and invasion through interacting with SMAD3 to promote SMAD3-induced transcriptional activity and the expression of EMT-related genes such as those encoding the transcription factors Twist-1 and Snail.
In summary, our studies demonstrate that TRB3 is a novel partner of SMAD3. The interaction of TRB3 and SMAD3 has a crucial role in the regulation of SMAD3-mediated transcriptional activity and in the reciprocally positive regulation of TRB3 expression. TRB3 augments TGF-b1-SMAD3 signaling through two mechanisms: (1) keeping SMAD3 in the nucleus by physical interaction; and (2) preventing the degradation of SMAD2 and phosphorylated SMAD3 by promoting the degradation of Smurf2 (Fig. 9) . Our studies indicate that TRB3 is important for maintaining the mesenchymal status of tumor cells and may be a potential therapeutic target for the treatment of human tumor metastasis.
Materials and Methods
Plasmids construction
HA-tagged TRB3 and its truncations: DC (amino acids 1-179), DN (amino acids 180-358) and KD (amino acids 71-315) were constructed in a pcDNA3.1-HA vector by standard subcloning. The TRB3-shRNA-targeting sequence has been reported previously (Du et al., 2003) . The sequence was subcloned into pSilencer TM 3.1-H1 hygro-expressing vector (Ambion, Texas, USA). A control shRNA oligonucleotide, which does not match any known human coding cDNA, was used as control. pTRB3-luc was generated by ligating the human TRB3 promoter region (-1038 to +847) with pGL3-basic. Myc-tagged SMAD3A and SMAD3D mutants were generated by PCR as described previously (Liu et al., 1997) . Full-length SMAD3 was subcloned in frame to the pGEX4T-1 to make GST fusion proteins. Smurf2-DDK/Myc expression plasmid was purchased from Origene (Rockville, MD, USA). The ubiquitin gene was synthesized according to the sequence published on NCBI web site (accession number: M17524) and cloned into pFLAG-CMV TM -2 expression plasmid. SBE4-luc reporter plasmid was obtained from Dr Bert Vogelstein of Johns Hopkins University Medical Institutions, Baltimore, MD. The 3TP-lux reporter plasmid was obtained from Dr Joan Massagué of Sloan-Kettering Institute, New York, NY.
Cells lines and transfection
All cell lines were obtained from the ATCC. Transient transfection was carried out using LipofectAMINE2000 (Invitrogen, Carlsbad, CA, USA) according to the manufacturer's instructions. To generate HepG2 cell populations stably expressing TRB3 shRNA, the control-shRNA and the TRB3-shRNA plasmids were both transfected into HepG2 cells with siPORT TM XP-1 tansfection reagent (Ambion) according to the manufacturer's instructions. After 24 hours of transfection, stable transfectants were selected in medium containing 200 mg/ml hygromycin (Calbiochem, San Diego, CA, USA) for 7 days. After two or three passages in the presence of hygromycin, the cultures were used for experiments without cloning.
Immunoprecipitation and western blotting
Cells were washed three times with phosphate-buffered saline, harvested, and lysed in co-immunoprecipitation (co-IP) buffer that has been described before (Du et al., 2003) . Total cell lysate (5 mg protein) was subjected to immunoprecipitation with appropriate antibodies, as indicated, overnight at 4˚C with gentle agitation, followed by incubation with protein A/G Plus-agarose for 2,4 hours at 4˚C. The immunocomplex was washed three times and then mixed with 23SDS sample buffer and boiled for 5 minutes. For western blotting, co-precipitates or whole cell extracts were resolved by SDS-PAGE and blotted on PVDF membranes (Millipore, Bedford, MA, USA). The membranes were immunoblotted with the indicated antibodies and developed using an ECL detection system (Amersham Bioscience, Piscataway, NJ, USA).
GST pull-down assay GST fusion constructs of SMAD3 were expressed in Escherichia coli and purified using glutathione-Sepharose 4B beads (Amersham Bioscience). Equal amounts of GST or GST fusion proteins bound to glutathione-Sepharose beads were incubated with lysates from HEK293T cells transiently transfected with TRB3-HA. Beads were washed three times and interacting proteins were detected by immunoblotting. Expression of GST fusion proteins was confirmed by Coomassie Blue staining.
Luciferase reporter assay
HEK293T or HepG2 cells were seeded on 12-well plates at a density of 2610 5 / well, and transfected with the indicated plasmids. TK-Renilla expression plasmid was used as an internal control. The total amount of plasmid per well was normalized by the addition of pcDNA3 empty vector. After 24 hours of transfection, cells were incubated in the presence (+) or absence (-) of TGF-b1 for another 24 hours. Cells were harvested with lysis buffer, and the luciferase activity was then measured using the dual luciferase assay kit according to the manufacturer's instruction (Promega, Madison, Wisconsin, USA).
Immunofluorescence microscopy
HepG2 cells were plated on sterile coverlips and transfected with the expression plasmids, as indicated, for 24 hours. Cells were fixed with 4% paraformaldehyde for 10 minutes at room temperature, permeabilized with 0.5% Triton X-100 for 10 minutes, and blocked with 3% BSA for 30 minutes at 37˚C. The coverslips were incubated with primary antibodies at 4˚C overnight. After washing three times with PBS, cells were stained with Alexa Fluor 594 goat anti-mouse IgG and FITC-conjugated goat anti-rabbit antibodies for 30 minutes at 37˚C then washed three times with PBS and mounted on glass slides. Images were acquired using a confocal microscope (Leica Microsystems Heidelberg GmbH, TCS SP2).
Cellular fractionation
To prepare the nuclear and cytoplasmic fractions, the cultured cells were lysed using a Nuclear and Cytoplasmic Protein Extraction Kit (Beyotime Institute of Biotechnology, Suzhou, China) following the manufacturer's instructions. Briefly, cells was washed with iced PBS and added to buffer A for 15 minutes and then centrifuged at 12,000 g for 15 minutes at 4˚C. The supernatants were collected as the cytoplasmic fraction. The pellet was washed with PBS and resuspended in a nuclear extraction buffer. The mixture was votexed vigorously for 15 seconds and put on ice for 10 minutes. The process was repeated 4 or 5 times, and then centrifuged again (12,000 g for 15 minutes, at 4˚C). The obtained supernatant was collected as the nuclear fraction. The separated cytoplasmic and nuclear fractions were subjected to SDS-PAGE and immunoblotting.
Cell migration and invasion assays
Transwell migration assays were performed using Transwell chambers with filter membranes of 8 mm pore size (Millipore). Chambers were precoated with 10 mg/ml fibronectin on the lower surface as previously described (Katoh et al., 2006) . Cells were starved overnight in assay medium [Dulbecco's modified Eagle's medium (DMEM) containing 0.4% FBS] and then seeded into the upper chamber (5610 4 cells per well in 0.4% FBS in DMEM). After 24 hours, non-migrating cells on the upper side of the filter were removed with a cotton swab. Cells migrated were stained and counted. Transwell invasion assays were done under the same conditions as the transwell migration assays, but before invasion assays, the polycarbonate filter was coated with Matrigel (30 mg/well; BD Bioscience, Bedford, MA, USA).
Semi-quantitative RT-PCR
Total RNA was extracted using TRIzol (Invitrogen) following the manufacturer's instructions. Reverse transcription of the total cellular RNA was carried out using oligo(dT) primers and M-MLV reverse transcriptase (Promega). PCR was performed using an Mycycler thermal cycler and analyzed using agarose gels.
Statistical analysis
Data are expressed as mean ¡ standard error of the mean (s.e.m.). Student's t-test was used for two-group comparisons. Comparisons between three or more groups were analyzed by one-way ANOVA followed by Duncan's test in SPSS 13.0 (SPSS Inc.). P,0.05 was considered statistically significant.
